Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
NCT ID:
NCT03831932
Group ID:
EG000
Title:
Phase 1b 400mg Telaglenastat HCl Cohort
Description:
Patients receive telaglenastat hydrochloride PO BID and osimertinib PO QD (starting cycle 1 day 16 of phase I). Patients undergo blood sample collection and may undergo x-ray imaging, CT scan, MRI, or PET scan throughout the study. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Biospecimen Collection: Undergo blood sample collection
Computed Tomography: Undergo CT scan
Magnetic Resonance Elastography: Undergo MRI
Osimertinib: Given PO
Positron Emission Tomography: Undergo PET scan
Telaglenastat Hydrochloride: Given PO
X-Ray Imaging: Undergo x-ray imaging
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
3
Other Number Affected:
3
Other Number At Risk:
3
Study:
NCT03831932
Results Section:
NCT03831932
Adverse Events Module:
NCT03831932